In addition, CBTR occurred more often in ER-positive DCIS patients than ER-negative DCIS patients (8.9 vs. 5.6 %), whereas CBTR rates after tamoxifen treatment were the same between these two patient groups [8]. Here, ESR1 is linked to ductal breast carcinoma in situ.